This business information is not released now.

This page is displayed by "Spiral" of PIPED BITS Co.,Ltd., which is a database management ASP service, our contracted partner.

Medical ProteoScope Co. Ltd.
Drug discovery support/Contract service
Medical care/Diagnosis/Medical equipment/Healthcare
Pharmaceutical/Drug Discovery
last update:2017/4/27

Delegates :
Motoo Saito

Incorporated :
November  18 , 2002

Paid in Capital :
50 Million yen  

Employees :
7 人

Address :
Yokohama Bio Industry Center 1-6 Suehiro-cho Tsurumi-ku, Yokohama-shi KANAGAWA

+81-45-508-0210 / +81-45-508-0220


Attachment :

Mission/Background :
MPS commits to contribute in maximizing therapeutic outcome of individual patients, personalized healthcare, by our first-in-class technology platform of clinical proteomics that discovers and then validates promising biomarkers. It is envisioned that the upcoming generation of personalized drugs for targeted and stratified patient treatment will break through in major disease areas such as lifestyle-related cancers, in particular lung cancers that have the highest mortality including a predisposing disorder chronic obstructive pulmonary disease. A clinical use of promising protein biomarkers will optimize individual therapeutic strategies by diagnosis, prediction, and prognosis on their disease status and treatments, and will and reduce medical costs by “Right Medication, Right Dose, Right Patient, Right Time, and Right Route for Individual Patients”.

Technology & Business
Our key-technology is the high performance mass spectrometry-based exploration of biomarker development which utilizes various clinical biospecimen including frozen and archived formalin-fixed tissues, blood, and proximal fluid. One of our innovative platforms is the biomarker development utilizing formalin-fixed paraffin-embedded (FFPE) tissues (or biopsy tissue specimen) followed by selected collection of cells of interest with laser microdissection (LMD).

An establishment of protein biomarker panels from clinical/biological spacemen is our core competence. MPS provides activities below.
-\tGlobal / targeted proteomic services for pharmaceutical companies
-\tGlobal / targeted proteomic services for research institutes
-\tHigh accuracy nano-flowLC-MS, MS/MS proteomic services
-\tProteome bioinformatic services of analysis/mining/statistical evaluation for high accuracy nano-flowLC-MS, MS/MS data

Products & Service
Products & Service Name
Drug design research support in clinical proteomics
Protein biomarker discovery from formalin fixed paraffin embedded (FFPE) tissue
verification phase

Sep.2011, Human Proteome Organization World Congress (HUPO 2011, Geneva, Swiss) Poster presentation

May 2012, the 60th American Society for Mass Spectrometry Congress (ASMS 2012, Vancouver) Symposium oral presentation

May 2012, American Urological Association, annual meeting (AUA 2012, San Diego) Poster presentation

Hot news

Alliance strategy
MPS explores scientific and business collaboration utilizing our strength in clinical proteomic development on protein biomarkers and druggable targets.

This page is displayed by "Spiral" of PIPED BITS Co.,Ltd., which is a database management ASP service, our contracted partner.